Citations to this article

Triplex formation inhibits HER-2/neu transcription in vitro.
S W Ebbinghaus, … , G Sanders, D M Miller
S W Ebbinghaus, … , G Sanders, D M Miller
Published November 1, 1993
Citation Information: J Clin Invest. 1993;92(5):2433-2439. https://doi.org/10.1172/JCI116850.
View: Text | PDF
Research Article Article has an altmetric score of 6

Triplex formation inhibits HER-2/neu transcription in vitro.

Abstract

Triplex-forming oligonucleotides (TFOs) have been shown to bind to target DNA sequences in several human gene promoters such as the c-myc oncogene, the epidermal growth factor receptor, and the dihydrofolate reductase genes. TFOs have been shown to inhibit transcription in vitro and gene expression in cell culture of the c-myc and other genes. The HER-2/neu oncogene, which is overexpressed in breast cancer and other human malignancies, contains a purine-rich sequence in its promoter, which is favorable for purine:purine:pyrimidine (R:R:Y) triplex formation. Although its function in the HER-2/neu promoter is unknown, this purine-rich site is homologous to a protein-binding sequence in the promoter of the epidermal growth factor receptor that is necessary for efficient transcription of this gene. We have shown that this sequence is a site for nuclear protein binding by incubation with a crude nuclear extract. We describe the formation of an interstrand triplex using a purine-rich oligonucleotide antiparallel to this purine-rich target sequence of the HER-2/neu promoter. Triplex formation by the oligonucleotide prevents protein binding to the target site in the HER-2/neu promoter in vitro. We have shown that this oligonucleotide is a potent and specific inhibitor of HER-2/neu transcription in an in vitro assay. The triplex target site contains a single pyrimidine base that does not conform to the R:R:Y triplex motif. In an attempt to abrogate the potentially destabilizing effects of this pyrimidine base on triplex formation, we have substituted an abasic linker for the pyrimidine residue in the triplex forming oligonucleotide. Triplex formation with the modified oligonucleotide appears to occur with approximately equivalent binding affinity. Triplex formation in the HER-2/neu oncogene promoter prevents transcription in vitro and may represent a future modality for specific inhibition of this gene in vivo.

Authors

S W Ebbinghaus, J E Gee, B Rodu, C A Mayfield, G Sanders, D M Miller

×

Total citations by year

Year: 2022 2021 2019 2018 2015 2014 2011 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1985 Total
Citations: 1 3 1 1 1 2 3 2 2 2 3 2 8 4 4 7 5 8 5 3 1 68
Citation information

Citations to this article (68)

Title and authors Publication Year
Non-canonical DNA structures: Diversity and disease association.
Bansal A, Kaushik S, Kukreti S 		Frontiers in Genetics 2022
Direct targeting of amplified gene loci for proapoptotic anticancer therapy
MK Tiwari, DA Colon-Rios, HC Tumu, Y Liu, E Quijano, A Krysztofiak, C Chan, E Song, DT Braddock, HW Suh, WM Saltzman, FA Rogers 		Nature Biotechnology 2021
Regulatory role of Non-canonical DNA Polymorphisms in human genome and their relevance in Cancer
N Pandya, SR Bhagwat, A Kumar 		Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021
Direct targeting of amplified gene loci for proapoptotic anticancer therapy.
Kaushik Tiwari M, Colon-Rios DA, Tumu HCR, Liu Y, Quijano E, Krysztofiak A, Chan C, Song E, Braddock DT, Suh HW, Saltzman WM, Rogers FA 		Nature Biotechnology 2021
Exploration of the Structure and Recognition of a G-quadruplex in the her2 Proto-oncogene Promoter and Its Transcriptional Regulation
X Cui, H Chen, Q Zhang, M Xu, G Yuan, J Zhou 		Scientific Reports 2019
Destabilization of DNA G-Quadruplexes by Chemical Environment Changes during Tumor Progression Facilitates Transcription
H Tateishi-Karimata, K Kawauchi, N Sugimoto 		Journal of the American Chemical Society 2018
Conformational diversity of single-stranded DNA from bacterial repetitive extragenic palindromes: Implications for the DNA recognition elements of transposases: Conformational Diversity of Single-Stranded REP DNA
T Charnavets, J Nunvar, I Nečasová, J Völker, KJ Breslauer, B Schneider 		Biopolymers 2015
Methods in Molecular Biology
AS Ricciardi, NA McNeer, KK Anandalingam, WM Saltzman, PM Glazer 		Methods in molecular biology (Clifton, N.J.) 2014
New Insights into Transcription Fidelity: Thermal Stability of Non-Canonical Structures in Template DNA Regulates Transcriptional Arrest, Pause, and Slippage
H Tateishi-Karimata, N Isono, N Sugimoto, C Schönbach 		PloS one 2014
DNA triplex-mediated inhibition of MET leads to cell death and tumor regression in hepatoma
G Singhal, MZ Akhter, DF Stern, SD Gupta, A Ahuja, U Sharma, NR Jagannathan, MR Rajeswari 		Cancer Gene Therapy 2011
International Review of Cell and Molecular Biology
A Chavez, M Smith, D Mehta 		International Review of Cell and Molecular Biology Volume 290 2011
The Primo Vascular System
KS Soh, KA Kang, DK Harrison 		2011
Pancreatic Cancer
J Kleeff, C Michalski, H Friess, MW B??chler 		Pancreas 2006
PNA−Nitrogen Mustard Conjugates Are Effective Suppressors of HER-2/neu and Biological Tools for Recognition of PNA/DNA Interactions
ZV Zhilina, AJ Ziemba, PE Nielsen, SW Ebbinghaus 		Bioconjugate Chemistry 2006
Targeting and Regulation of the HER-2/neu Oncogene Promoter with Bis-Peptide Nucleic Acids
AJ Ziemba, ZV Zhilina, Y Krotova-Khan, L Stankova, SW Ebbinghaus 		Oligonucleotides 2005
Cancer Gene Therapy
M Yamamoto, DT Curiel 		Technology in cancer research & treatment 2005
Triplex Forming Oligonucleotides – Tool for Gene Targeting
M Mojžíšek 		Acta Medica (Hradec Kralove, Czech Republic) 2004
Synthesis and Evaluation of a Triplex-Forming Oligonucleotide−Pyrrolobenzodiazepine Conjugate
ZV Zhilina, AJ Ziemba, JO Trent, MW Reed, V Gorn, Q Zhou, W Duan, L Hurley, SW Ebbinghaus 		Bioconjugate Chemistry 2004
Strategies for cancer gene therapy
RM Hughes 		Journal of Surgical Oncology 2003
Gene therapy for ovarian cancer: progress and potential
T Kirby, D Curiel, R Alvarez 		Hematology/Oncology Clinics of North America 2003
A Bis-Alkylating Triplex Forming Oligonucleotide Inhibits Intracellular Reporter Gene Expression and Prevents Triplex Unwinding Due to Helicase Activity
AJ Ziemba, MW Reed, KD Raney, AB Byrd, SW Ebbinghaus 		Biochemistry 2003
Importance of Sp1 consensus motifs in the MYCN promoter
TH Inge, LK Casson, W Priebe, JO Trent, KE Georgeson, DM Miller, PJ Bates 		Surgery 2002
External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator
S Asada, Y Choi, M Yamada, SC Wang, MC Hung, J Qin, M Uesugi 		Proceedings of the National Academy of Sciences 2002
Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells
C Shen, A Buck, G Mehrke, B Polat, H Gross, M Bachem, S Reske 		Nucleic Acids Research 2001
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma
A Ly, HT Duc, M Kalamarides, LA Trojan, Y Pan, A Shevelev, JC François, T Noël, A Kane, D Henin, DD Anthony, J Trojan 		Molecular pathology : MP 2001
Triplex formation by morpholino oligodeoxyribonucleotides in the HER-2/neu promoter requires the pyrimidine motif
J Basye, JO Trent, D Gao, SW Ebbinghaus 		Nucleic Acids Research 2001
Repair of triplex-directed DNA alkylation by nucleotide excision repair
A Ziemba, LC Derosier, R Methvin, CY Song, E Clary, W Kahn, D Milesi, V Gorn, M Reed, S Ebbinghaus 		Nucleic Acids Research 2001
EXLOITING GENETIC ALTERATIONS TO DESIGN NOVEL THERAPIES FOR CANCER
TP Cripe, CL Mackall 		Hematology/Oncology Clinics of North America 2001
Untangling the ErbB signalling network
Y Yarden, MX Sliwkowski 		Nature Reviews Molecular Cell Biology 2001
Presentation of the Southern Society for Clinical Investigation 2001 Founders’ Medal to Dr. Donald M. Miller
JC Bennett 		The American Journal of the Medical Sciences 2001
A Molecular Beacon Strategy for the Thermodynamic Characterization of Triplex DNA: Triplex Formation at the Promoter Region of Cyclin D1
T Antony, T Thomas, LH Sigal, A Shirahata, TJ Thomas 		Biochemistry 2001
Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells
T Suzuki, B Anderegg, T Ohkawa, A Irie, O Engebraaten, M Halks-Miller, PS Holm, DT Curiel, M Kashani-Sabet, KJ Scanlon 		Gene Therapy 2000
Ets regulation of the erbB2 promoter
GK Scott, CH Chang, KM Erny, F Xu, WJ Fredericks, FJ Rauscher, AD Thor, CC Benz 		Oncogene 2000
Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells
RM Neve, H Sutterlüty, N Pullen, HA Lane, JM Daly, W Krek, NE Hynes 		Oncogene 2000
Inhibition of Gene Expression and Cell Proliferation by Triple Helix-Forming Oligonucleotides Directed to the c-myc Gene
CV Catapano, EM McGuffie, D Pacheco, GM Carbone 		Biochemistry 2000
Differential Effects of Cyclopolyamines on the Stability and Conformation of Triplex DNA
T Antony, M Musso, MW Hosseini, G Brand, NJ Greenfield, T Thomas, MW van Dyke, T Thomas 		Antisense and Nucleic Acid Drug Development 1999
The integral divalent cation within the intermolecular purine*purine{middle dot}pyrimidine structure: a variable determinant of the potential for and characteristics of the triple helical association
SW Blume, J Lebowitz, W Zacharias, V Guarcello, CA Mayfield, SW Ebbinghaus, P Bates, DE Jones, J Trent, N Vigneswaran, DM Miller 		Nucleic Acids Research 1999
Triple Helix Forming Oligonucleotides
C Malvy, A Harel-Bellan, LL Pritchard 		1999
Cationic Peptide Mediated Oligonucleotide Delivery to DU145 Prostate Cancer Cells - Cell Surface Binding Detected by High Resolution SEM
JF Karr, RP Apkarian, JA Petros 		Microscopy and Microanalysis 1999
Triplex-directed modification of genes and gene activity
KM Vasquez, JH Wilson 		Trends in Biochemical Sciences 1998
Intracellular Expression of the Anti-erbB-2 sFv N29 Fails to Accomplish Efficient Target Modulation
JE Grim, GP Siegal, RD Alvarez, DT Curiel 		Biochemical and Biophysical Research Communications 1998
Antisense Research and Application
ST Crooke 		1998
Intrabodies
WA Marasco 		1998
A Novel Triplex-Forming Oligonucleotide Targeted to Human Cyclin D1 ( bcl -1, Proto-Oncogene) Promoter Inhibits Transcription in HeLa Cells
HG Kim, DM Miller 		Biochemistry 1998
Inhibition of Transcription Elongation in the HER-2/neu Coding Sequence by Triplex-Directed Covalent Modification of the Template Strand
SW Ebbinghaus, H Fortinberry, HB Gamper 		Biochemistry 1998
Inhibition of Transcription of the Human c- myc Protooncogene by Intermolecular Triplex
HG Kim, JF Reddoch, C Mayfield, S Ebbinghaus, N Vigneswaran, S Thomas, DE Jones, DM Miller 		Biochemistry 1998
Oligonucleotides as modulators of cancer gene expression
LD Curcio, DY Bouffard, KJ Scanlon 		Pharmacology & Therapeutics 1997
Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription
N Bianchi, C Rutigliano, M Passadore, M Tomassetti, L Pippo, C Mischiati, G Feriotto, R Gambari 		Biochemical Journal 1997
Divalent transition metal cations counteract potassium-induced quadruplex assembly of oligo(dG) sequences
SW Blume, V Guarcello, W Zacharias, DM Miller 		Nucleic Acids Research 1997
Factors influencing the extent and selectivity of alkylation within triplexes by reactive G/A motif oligonucleotides
JN Lampe, IV Kutyavin, R Rhinehart, MW Reed, RB Meyer, HB Gamper 		Nucleic Acids Research 1997
Effects of Chain Length Modification and Bis(ethyl) Substitution of Spermine Analogs on Purine−Purine−Pyrimidine Triplex DNA Stabilization, Aggregation, and Conformational Transitions
M Musso, T Thomas, A Shirahata, LH Sigal, MW Dyke, TJ Thomas 		Biochemistry 1997
Solution structure of an antiparallel purine motif triplex containing a T·CG pyrimidine base triple
J Ji, ME Hogan, X Gao 		Structure 1996
Section Review Oncologic, Endocrine & Metabolic: Gene therapy for cancer therapeutics
G Bilbao, DT Curiel 		Expert Opinion on Therapeutic Patents 1996
Binding of THZif-1, a MAZ-like Zinc Finger Protein to the Nuclease-hypersensitive Element in the Promoter Region of the c- MYC Protooncogene
O Sakatsume, H Tsutsui, Y Wang, H Gao, X Tang, T Yamauchi, T Murata, K Itakura, KK Yokoyama 		The Journal of biological chemistry 1996
Perspectives in Supramolecular Chemistry: Supramolecular Control of Structure and Reactivity
AD Hamilton 		1996
Influence of GC and AT Specific DNA Minor Groove Binding Drugs on Intermolecular Triplex Formation in the Human c-Ki-ras Promoter
N Vigneswaran, CA Mayfield, B Rodu, R James, HG Kim, DM Miller 		Biochemistry 1996
Stabilization of DNA Triple-Helix Formation by Appended Cationic Peptides
CH Tung, KJ Breslauer, S Stein 		Bioconjugate Chemistry 1996
Calorimetric Analysis of Triple Helices Targeted to the d(G 3 A 4 G 3 )·d(C 3 T 4 C 3 ) Duplex
PV Scaria, RH Shafer 		Biochemistry 1996
Torsionally-strained DNA and intermolecular purine-purine-pyrimidine triple-helix formation
M Musso, MW Dyke 		Molecular and Cellular Biochemistry 1996
Targeted tumor killing via an intracellular antibody against erbB-2
J Deshane, GP Siegal, RD Alvarez, MH Wang, M Feng, G Cabrera, T Liu, M Kay, DT Curiel 		Journal of Clinical Investigation 1995
Effect of competing self-structure on triplex formation with purine-rich oligodeoxynucleotides containing GA repeats
SB Noonberg, JC François, T Garestier, C Hélène 		Nucleic Acids Research 1995
Characteristics of triplex-directed photoadduct formation by psoralen-linked oligodeoxynucleotides
PJ Bates, VM Macaulay, MJ McLean, TC Jenkins, AP Reszka, CA Laughton, S Neidle 		Nucleic Acids Research 1995
Inhibition of Nuclear Protein Binding to Two Sites in the Murine c-myc Promoter by Intermolecular Triplex Formation
JF Reddoch, DM Miller 		Biochemistry 1995
Inhibition of in Vitro Transcription by a Triplex-Forming Oligonucleotide Targeted to Human c-myc P2 Promoter
HG Kim, D Miller 		Biochemistry 1995
Oligodeoxyribonucleotide length and sequence effects on intermolecular purine-purine-pyrimidine triple-helix formation
AJ Cheng, MW van Dyke 		Nucleic Acids Research 1994
Triplex formation at the rat neu oncogene promoter
JE Gee, RL Yen, MC Hung, ME Hogan 		Gene 1994
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal 		Advances in Pharmacology 1994
Ovarian Cancer
DS Alberts, EA Surwit 		1985

Advertisement